Replacing defective microglia can halt ALSP—a fatal neurodegenerative disease—in mice and humans, offering hope for broader brain therapies.

Around 2,500 people are living with sickle cell disease in the Bay State, and they are advocating for a bill that would improve quality of life for all those dealing with the disease.

The discovery may explain why cutting edge CAR T-cell therapy has managed to revolutionized treatment for blood cancer but ...